Imperagen

Seed
imperagen.com AI & Machine Learning Manchester, United Kingdom
Total Funding $4.2M
Latest Round Undisclosed Seed
Last Announced May 20, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Imperagen

Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Seed
Global Headquarters Manchester, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website imperagen.com
Domain Registered Date Nov 3, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Seed announced

    startupintros.com

  2. Capital Raise

    Raised $4,230,000 · Seed

    startupintros.com

  3. Milestone

    Website domain registered

    imperagen.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Imperagen.

Funding History

2 Rounds
Seed · May 20, 2026
Seed · Aug 9, 2022

Founders & Leadership

3

Andrew Currin

Founder

Work email & phone locked Unlock →

Andy Almond

Founder

Work email & phone locked Unlock →

Timothy Eyes

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts